03.05.2024 | Tracker
Top 50 Pharma Tracker: eHCPs Thank Pharma for Supporting American Congresses
The Top 50 Pharmaceutical Companies mentioned by eHCPs on X
April Rank | March Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
---|---|---|---|---|---|
1 | 1 | Pfizer | 2,615 | 300 | 2 |
2 | 2 | Moderna | 1,506 | 83 | 15 |
3 | 4 | AstraZeneca | 876 | 183 | 2 |
4 | 3 | Johnson & Johnson | 728 | 115 | 3 |
5 | 5 | GSK | 392 | 137 | 10 |
6 | 11 | Abbott | 248 | 229 | 10 |
7 | 7 | Bayer | 243 | 46 | 2 |
8 | 8 | Roche | 195 | 83 | 25 |
9 | 20 | BioNTech | 192 | 54 | 5 |
10 | 12 | Novavax | 184 | 19 | 4 |
11 | 9 | Gilead Sciences | 168 | 80 | 1 |
12 | 6 | Novo Nordisk | 159 | 89 | 5 |
13 | 18 | Novartis | 156 | 126 | 5 |
14 | 16 | Sanofi | 137 | 78 | 8 |
15 | 10 | Lilly | 135 | 84 | 1 |
16 | 15 | AbbVie | 123 | 92 | 2 |
17 | 19 | Merck & Co | 112 | 69 | 6 |
18 | 21 | BMS | 92 | 84 | 3 |
19 | 22 | Takeda | 92 | 83 | 0 |
20 | 24 | Servier | 69 | 31 | 7 |
21 | 23 | Amgen | 57 | 47 | 2 |
22 | 14 | Boehringer Ingelheim | 53 | 34 | 0 |
23 | 31 | Otsuka | 46 | 12 | 0 |
24 | 13 | Daiichi Sankyo | 39 | 28 | 4 |
25 | 17 | Fresenius | 39 | 29 | 2 |
26 | 27 | Regeneron | 35 | 20 | 0 |
27 | 25 | Organon | 31 | 3 | 0 |
28 | 36 | Vertex | 29 | 28 | 0 |
29 | 35 | Biogen | 27 | 15 | 0 |
29 | 41 | Viatris | 27 | 0 | 0 |
29 | 41 | CSL | 27 | 23 | 3 |
32 | 44 | Menarini | 25 | 1 | 1 |
33 | 32 | Teva | 20 | 9 | 1 |
34 | 29 | Ipsen | 16 | 8 | 1 |
34 | 38 | Eisai | 16 | 7 | 0 |
36 | 28 | UCB | 15 | 15 | 5 |
37 | 26 | Astellas | 11 | 7 | 0 |
38 | 30 | Grifols | 10 | 0 | 0 |
38 | 38 | Bausch | 10 | 5 | 2 |
38 | 43 | Incyte | 10 | 8 | 0 |
41 | 40 | Jazz Pharmaceuticals | 9 | 5 | 0 |
42 | 33 | Merck KGaA | 4 | 4 | 2 |
43 | 46 | Chugai | 3 | 2 | 2 |
44 | 33 | Sun | 2 | 1 | 0 |
44 | 37 | Perrigo | 2 | 1 | 0 |
46 | 45 | CSPC | 1 | 0 | 0 |
50 | 46 | Horizon | 0 | 0 | 0 |
50 | 50 | Shanghai | 0 | 0 | 0 |
50 | 50 | Sino | 0 | 0 | 0 |
50 | 50 | Jiangsu Hengrui | 0 | 0 | 0 |
April’s insights from eHCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by eHCPs on X in April 2024 were Pfizer, Moderna, AstraZeneca, Johnson & Johnson and GSK.
CREATION.co identified 8,105 eHCP mentions of pharmaceutical companies in April 2024, increasing by 13.6% over the previous month.
Between 05 and 10 April, the American Association for Cancer Research 2024 congress took place, with pharmaceutical companies and HCPs attending to get the latest updates in the world of oncology. Merck, Takeda, Amgen and others revealed data, partnerships and pipeline information which captured HCPs’ attention. Oncologist Wafik S. El-Deiry provided regular updates on X (formerly Twitter) for his peers, sharing the news as it was revealed.
Listening to Dr. Scot Ebbinghaus at @Merck speak about portfolio and partnering in oncology.
More than immunotherapy but with respect to IO there is activity in adjuvant setting for example bladder and melanoma.
@AACR Oncology Industry Partnering Event in San Diego #AACR24 pic.twitter.com/pT1wH3iEFG— Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) April 5, 2024
Shared by an eHCP
On 25 April, World Malaria Day, eHCPs shared a post from Gavi as they celebrated the news that Benin, Liberia and Sierra Leone would be launching a large-scale rollout of the first malaria vaccine for children, tagging GSK who developed the vaccine.
Congratulations Benin, Liberia and Sierra Leone for launching large-scale rollouts of the world’s first malaria vaccine targeting millions of children! https://t.co/FTzjwd8r9y #WorldMalariaDay @WHO, @UNICEF, @GSK, @UNITAID, @GlobalFund, @MedAccessUK, @PATHTweets, @USAIDGH
— Gavi, the Vaccine Alliance (@gavi) April 25, 2024
Shared by 5 eHCPs
On 30 April, the final day of the American Association of Thoracic Surgery Congress took place. eHCPs thanked AstraZeneca and other organisations for sponsoring the event and supporting the #WomeninMedicine initiative.
Thank you to all our WTS-WICTA Reception Sponsors at #AATS2024: @AstraZeneca, @Medtronic, @Abiomed, and @ETHICON. We greatly appreciate your support in making this reception possible for our organizations.
#WTS #WICTA #WomeninMedicine pic.twitter.com/piA4NWroMv— WomenInThoracicSurg (@WomenInThoracic) April 30, 2024
Shared by 3 eHCPs
The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:
- A press release from AstraZeneca discussing Imfinzi’s phase 3 trial results.
- A study discussing COVID-19 vaccine side effects.
- A press release from Abbott discussing the approval of TriClip for the repair of leaky tricuspid heart valve
——
Find out how the conversation is changing in other Top 50 Trackers and new analysis of the online HCP conversation in a variety of topics.
You can also receive these updates and more straight to your inbox by signing up to CREATION.co’s monthly eJournal and if you want to learn more about tracking the voice of the HCP online at congress watch our webinar: Unlocking hidden HCP influence at congress.
Methodology notes:
- In April 2024, CREATION Pinpoint® identified 8,105 posts on X (Twitter) from 3,407 individual eHCPs mentioning a Top 50 Pharmaceutical company (based on revenue).
- Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 30 April 2024.
- Unless otherwise specified, mentions of a company are not limited to its X account(s).
- In some cases, a post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In April 2024, 37 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.